Rein Ther­a­peu­tics study on clin­i­cal hold; Beam up­dates sick­le cell ther­a­py da­ta

Plus, news about En­liv­en Ther­a­peu­tics, Mer­ck’s Keytru­da and Celldex:

FDA places hold on Rein study: The agency has “non-clin­i­cal re­quests” for Rein Ther­a­peu­tics’ Phase …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER